Literature DB >> 2648921

Methotrexate in rheumatoid arthritis. Feedback on American College of Physicians guidelines.

P Tugwell1, K Bennett, M Bell, M Gent.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2648921     DOI： 10.7326/0003-4819-110-8-581

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  8 in total

1.  Nocardia asteroides pneumonia complicating low dose methotrexate treatment of refractory rheumatoid arthritis.

Authors:  J J Cornelissen; L J Bakker; M J Van der Veen; M Rozenberg-Arska; J W Bijlsma
Journal:  Ann Rheum Dis       Date:  1991-09       Impact factor: 19.103

Review 2.  The use of disease modifying antirheumatic drugs in the management of rheumatoid arthritis.

Authors:  L E Hart; P Tugwell
Journal:  Postgrad Med J       Date:  1989-12       Impact factor: 2.401

3.  Low-dose oral methotrexate in refractory inflammatory bowel disease.

Authors:  T H Baron; C D Truss; C O Elson
Journal:  Dig Dis Sci       Date:  1993-10       Impact factor: 3.199

Review 4.  Methotrexate in rheumatoid arthritis: can current knowledge and experience justify its use as a first-line disease-modifying agent?

Authors:  S Tariq; S M Tariq
Journal:  Postgrad Med J       Date:  1993-10       Impact factor: 2.401

Review 5.  Methotrexate-related pulmonary complications in rheumatoid arthritis.

Authors:  P Barrera; R F Laan; P L van Riel; P N Dekhuijzen; A M Boerbooms; L B van de Putte
Journal:  Ann Rheum Dis       Date:  1994-07       Impact factor: 19.103

Review 6.  Outcomes related to methotrexate dose and route of administration in patients with rheumatoid arthritis: a systematic literature review.

Authors:  Susan M Goodman; Bruce N Cronstein; Vivian P Bykerk
Journal:  Clin Exp Rheumatol       Date:  2014-12-23       Impact factor: 4.473

Review 7.  Methotrexate in rheumatoid arthritis. An update.

Authors:  B Bannwarth; L Labat; Y Moride; T Schaeverbeke
Journal:  Drugs       Date:  1994-01       Impact factor: 9.546

Review 8.  Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.

Authors:  Beverley Shea; Michael V Swinden; Elizabeth Tanjong Ghogomu; Zulma Ortiz; Wanruchada Katchamart; Tamara Rader; Claire Bombardier; George A Wells; Peter Tugwell
Journal:  Cochrane Database Syst Rev       Date:  2013-05-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.